Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice.
Visaggi P, Solinas I, Baiano Svizzero F, Bottari A, Barberio B, Lorenzon G, Ghisa M, Maniero D, Marabotto E, Bellini M, de Bortoli N, Savarino EV. Visaggi P, et al. Among authors: marabotto e. Diagnostics (Basel). 2023 Aug 30;13(17):2806. doi: 10.3390/diagnostics13172806. Diagnostics (Basel). 2023. PMID: 37685343 Free PMC article. Review.
Hepatocellular carcinoma in patients with cryptogenic cirrhosis.
Giannini EG, Marabotto E, Savarino V, Trevisani F, di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M; Italian Liver Cancer (ITALICA) Group. Giannini EG, et al. Among authors: marabotto e. Clin Gastroenterol Hepatol. 2009 May;7(5):580-5. doi: 10.1016/j.cgh.2009.01.001. Clin Gastroenterol Hepatol. 2009. PMID: 19418607
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, Parodi A, Sammito G, Gemignani L, Bodini G, Savarino V. Savarino E, et al. Among authors: marabotto e. Am J Gastroenterol. 2010 May;105(5):1053-61. doi: 10.1038/ajg.2009.670. Epub 2009 Dec 8. Am J Gastroenterol. 2010. PMID: 19997095
Overweight is a risk factor for both erosive and non-erosive reflux disease.
Savarino E, Zentilin P, Marabotto E, Bonfanti D, Inferrera S, Assandri L, Sammito G, Gemignani L, Furnari M, Dulbecco P, Savarino V. Savarino E, et al. Among authors: marabotto e. Dig Liver Dis. 2011 Dec;43(12):940-5. doi: 10.1016/j.dld.2011.07.014. Epub 2011 Sep 22. Dig Liver Dis. 2011. PMID: 21944835
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F, Frigo AC, Fazio V, Marabotto E, Savarino V. Savarino E, et al. Among authors: marabotto e. Am J Gastroenterol. 2013 Nov;108(11):1731-42. doi: 10.1038/ajg.2013.287. Epub 2013 Sep 10. Am J Gastroenterol. 2013. PMID: 24019080 Clinical Trial.
Esophageal motility abnormalities in gastroesophageal reflux disease.
Martinucci I, de Bortoli N, Giacchino M, Bodini G, Marabotto E, Marchi S, Savarino V, Savarino E. Martinucci I, et al. Among authors: marabotto e. World J Gastrointest Pharmacol Ther. 2014 May 6;5(2):86-96. doi: 10.4292/wjgpt.v5.i2.86. World J Gastrointest Pharmacol Ther. 2014. PMID: 24868489 Free PMC article. Review.
115 results